Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Transplant Proc ; 54(9): 2500-2502, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36319494

RESUMO

BACKGROUND: The outcomes of heart-lung transplant (HLT) are worse than those of heart transplant (HT) and lung transplant alone; this and the availability of mechanical assistance have meant that the indications for HLT have been changing. This study aims to analyze the evolution of indications for HLT in a country of 47 million inhabitants. METHODS: We performed a retrospective observational study of all HLTs performed in Spain (performed in 2 centers) from 1990 to 2020. The total number of patients included was 1751 (HT 1673 and HLT 78). After clinical adjustment, overall survival was compared between the 2 groups. Seven etiological subgroups were considered within the HLT group: (1) cardiomyopathy with pulmonary hypertension (CM + PH);, (2) Eisenmenger syndrome, (3) congenital heart disease without Eisenmenger syndrome, (4) idiopathic pulmonary arterial hypertension (IPAH), (5) cystic fibrosis, (6) chronic obstructive pulmonary disease (COPD) and/or emphysema), and (7) diffuse interstitial lung disease. RESULTS: There were a large number of differences between patients with HLT vs HT. HLT had a 2.69-fold increased probability of death in the first year compared with HT. The indications for HLT have changed over the years. In the recent period the indications are mainly congenital heart disease and Eisenmenger syndrome, with some cases of CM + PH. Other indications for HLT have virtually disappeared, mainly lung diseases (IPAH, COPD, cystic fibrosis). Median survival was low in CM + PH (18 days), diffuse interstitial lung disease (29 days), and ischemic heart disease (114 days); intermediate in Eisenmenger syndrome (600 days); and longer in IPAH, COPD and/or emphysema, and cystic fibrosis. CONCLUSIONS: HLT is a procedure with high mortality. This and mechanical assists mean that the indications have changed over the years. Etiological analysis is of utmost interest to take advantage of organs and improve survival.


Assuntos
Fibrose Cística , Complexo de Eisenmenger , Enfisema , Cardiopatias Congênitas , Transplante de Coração-Pulmão , Hipertensão Pulmonar , Doenças Pulmonares Intersticiais , Transplante de Pulmão , Doença Pulmonar Obstrutiva Crônica , Humanos , Complexo de Eisenmenger/cirurgia , Espanha , Fibrose Cística/cirurgia , Transplante de Pulmão/métodos , Hipertensão Pulmonar/cirurgia , Hipertensão Pulmonar Primária Familiar , Doença Pulmonar Obstrutiva Crônica/cirurgia
2.
Ann Thorac Surg ; 110(1): e1-e4, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-31981501

RESUMO

A giant coronary artery aneurysm is an infrequent anomaly encountered as an incidental finding. An even more rare condition is its association with a coronary artery fistula. We report the case of a 61-year-old woman that combines two of the rarest coronary anomalies: a 70-mm giant circumflex aneurysm with an arteriovenous fistula tract draining to the superior vena cava. Considering the unique display of anatomy, the surgery was guided with 3-dimensional printing technology. Direct fistula occlusion near its outflow union, orifice source closure, aneurysmal sac exclusion, and two coronary artery bypass grafts were surgically performed. The postoperative course was satisfactory.


Assuntos
Fístula Arteriovenosa/cirurgia , Aneurisma Coronário/cirurgia , Anomalias dos Vasos Coronários/cirurgia , Impressão Tridimensional , Procedimentos Cirúrgicos Vasculares/métodos , Veia Cava Superior/anormalidades , Fístula Arteriovenosa/diagnóstico , Aneurisma Coronário/diagnóstico , Angiografia Coronária , Anomalias dos Vasos Coronários/diagnóstico , Feminino , Humanos , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X , Veia Cava Superior/diagnóstico por imagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA